Correlation Between Allient and Estrella Immunopharma

Can any of the company-specific risk be diversified away by investing in both Allient and Estrella Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allient and Estrella Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Allient and Estrella Immunopharma, you can compare the effects of market volatilities on Allient and Estrella Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allient with a short position of Estrella Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allient and Estrella Immunopharma.

Diversification Opportunities for Allient and Estrella Immunopharma

0.62

Correlation Coefficient

Allient  Estrella Immunopharma

Poor diversification

The 3 months correlation between Allient and Estrella is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Allient and Estrella Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Estrella Immunopharma and Allient is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allient are associated (or correlated) with Estrella Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Estrella Immunopharma has no effect on the direction of Allient i.e., Allient and Estrella Immunopharma go up and down completely randomly.

Pair Corralation between Allient and Estrella Immunopharma

Given the investment horizon of 90 days Allient is expected to generate 0.46 times more return on investment than Estrella Immunopharma. However, Allient is 2.18 times less risky than Estrella Immunopharma. It trades about 0.02 of its potential returns per unit of risk. Estrella Immunopharma is currently generating about 0.0 per unit of risk. If you would invest  2,358  in Allient on December 22, 2024 and sell it today you would earn a total of  23.00  from holding Allient or generate 0.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Allient  vs.  Estrella Immunopharma

Allient

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Allient are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Allient is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Estrella Immunopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Estrella Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Estrella Immunopharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Allient and Estrella Immunopharma

The main advantage of trading using opposite Allient and Estrella Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allient position performs unexpectedly, Estrella Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Estrella Immunopharma will offset losses from the drop in Estrella Immunopharma's long position.

The idea behind Allient and Estrella Immunopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.